Thursday, 6 June 2013

Autologous hematopoietic stem cell transplant study results

Source: www.medpagetoday.com

ORLANDO -- High-dose immunosuppressant therapy and autologous hematopoietic stem cell transplant (HSCT) induced durable freedom from relapses and MRI lesions in patients with multiple sclerosis, researchers reported here.